Algo version: 0.98b
GMAB is listed at the NASDAQ Exchange
GMAB [GMAB]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is GMAB stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Genmab A/S 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $3.86, you would have made a profit of $23.66 per share or 612.95%

Yes, the average daily trading liquidity for Genmab A/S is $15.33 million. You should therefore be able to get in and out of your positions relatively fast.

Genmab A/S has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 5.60, the company's ability to pay off the debt is good. Genmab A/S has a very good net profit margin of 30.69% and should have very high tolerances against inflation.

We have calculated the inflation risk for Genmab A/S to be low [0 out of 1]